28 March 2007 · This page forms part of a resource on medication related patient safety alerts issued by the National Patient Safety Agency (NPSA) between 2002 and 2012…
27 November 2009 · Key risks emerging from the review of serious incidents reported by the NHS to its National Reporting and Learning System (NRLS) were shared in in…
26 February 2010 · Key risks emerging from the review of serious incidents reported by the NHS to its National Reporting and Learning System (NRLS) were shared in in…
16 December 2010 · This page forms part of a resource on medication related patient safety alerts issued by the National Patient Safety Agency (NPSA) between 2002 and 2012…
14 February 2011 · Key risks emerging from the review of serious incidents reported by the NHS to its National Reporting and Learning System (NRLS) were shared in in…
25 March 2011 · Key risks emerging from the review of serious incidents reported by the NHS to its National Reporting and Learning System (NRLS) were shared in in…
3 February 2016 · NOACs offer convenient fixed dosing without need for routine coagulation monitoring and they have predictable pharmacokinetics, fewer interactions and quicker onset (and offset) of action…
17 July 2018 · In May 2010, the Medicines and Healthcare products Regulatory Agency (MHRA) issued a safety update to healthcare professionals in the UK highlighting the risk of…
30 July 2018 · The development of OPAT (Outpatient Parenteral Antibiotic Therapy) services and other outpatient intravenous therapies has been rapid over recent years and there are many models…
1 August 2018 · This Medicines Q&A summarises published studies or case reports concerning the pharmacological treatment of drug-induced hypersalivation (drooling or sialorrhoea), particularly hypersalivation caused by clozapine. Update…